Delivra Health Brands Inc.
DHBUF
$0.12
-$0.01-4.18%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.12% | 10.06% | 4.93% | 0.81% | 8.66% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.12% | 10.06% | 4.93% | 0.81% | 8.66% |
| Cost of Revenue | 4.72% | 13.15% | 7.07% | 10.42% | 14.86% |
| Gross Profit | -0.49% | 7.11% | 2.92% | -7.31% | 3.07% |
| SG&A Expenses | -9.93% | -2.50% | 6.51% | 18.02% | 20.69% |
| Depreciation & Amortization | -52.02% | -28.04% | -6.12% | -4.33% | -3.21% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -7.26% | 1.83% | 5.50% | 12.20% | 15.44% |
| Operating Income | 84.01% | 68.67% | -15.63% | -714.33% | -135.41% |
| Income Before Tax | -2,188.06% | -585.06% | -233.67% | 86.33% | 101.64% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2,188.06% | -585.06% | -233.67% | 86.33% | 101.64% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2,188.06% | -585.06% | -233.67% | 86.33% | 101.64% |
| EBIT | 84.01% | 68.67% | -15.63% | -714.33% | -135.41% |
| EBITDA | 259.85% | 696.14% | -31.10% | -130.14% | -134.29% |
| EPS Basic | -27.14% | -182.81% | -330.83% | 46.70% | 77.78% |
| Normalized Basic EPS | 73.49% | 60.87% | -11.35% | 5.34% | 31.40% |
| EPS Diluted | -27.14% | -182.81% | -330.83% | 46.70% | 77.78% |
| Normalized Diluted EPS | 73.49% | 60.87% | -11.35% | 5.34% | 31.40% |
| Average Basic Shares Outstanding | -4.59% | -1.00% | 1.92% | 21.02% | 28.12% |
| Average Diluted Shares Outstanding | -4.59% | -1.00% | 1.92% | 21.02% | 28.12% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |